Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,585.38
(
0.29%
)
US TECH 100
29,525.20
(
0.34%
)
Dow Jones
51,051.27
(
0.75%
)
Brent Oil
90.55
(
-1.77%
)
Bitcoin
74,043.45
(
0.69%
)
News Focus
News Focus
Post# of 257655
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123035
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: marthambles post# 212385

Friday, 07/21/2017 11:53:31 AM

Friday, July 21, 2017 11:53:31 AM

Post# of 257655
RVNC—Cantor Fitzgerald initiates coverage with $50 price target:

https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Cantor+Fitzgerald+Starts+Revance+Therapeutic+%28RVNC%29+at+Overweight/13116102.html

It seems reasonable to infer that CF will be the lead underwriter in the (presumed) near-term financing.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today